• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BRANCHBURG STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 25, FIRM; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BRANCHBURG STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 25, FIRM; MESH, SURGICAL Back to Search Results
Catalog Number 2025002
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Hernia (2240); Impaired Healing (2378); Post Operative Wound Infection (2446)
Event Date 01/28/2015
Event Type  Injury  
Manufacturer Narrative
This legal event is being reported as serious injury due to the reported recurrence with surgical intervention.The lot associated with this event was not reported and remains unknown; therefore an internal investigation into the device history records could not be performed.No strattice devices were returned for evaluation.Based on the limited information, including no identification of the lot number, and without relevant patient factors, a relationship between the event and the strattice could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Event Description
Limited information was reported through a legal event that a patient was implanted with strattice firm on (b)(6) 2014 and a 2nd strattice firm on (b)(6) 2015.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.This is the same event and the same patient reported under patient identifier (b)(6) (emdr-16127).This emdr is being submitted for the suspect product, first strattice firm.
 
Manufacturer Narrative
A review of the device history record for strattice lot s11228 has been initiated.If any new, changed or corrected information is noted, a supplemental report will be submitted.This is a known potential adverse event addressed in the product labeling.Without relevant patient factors, a relationship between the strattice and this event could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Event Description
This is follow up#1 to report on (b)(6) 2024, pmqa received notification from legal that the plaintiff profile form was received associated with this event.This record is for the device implanted (b)(6) 2014.As per the ppf form, the patient underwent a ¿ventral hernia¿ surgery and was implanted with strattice device on (b)(6) 2014.The patient underwent an ¿exploratory laparotomy, lysis of adhesions, ileostomy takedown and redo ventral hernia repair with strattice mesh¿ on (b)(6) 2015.The patient was implanted with another strattice device on that date.As per the ppf form, the patient claims the implantation and failure of the mesh caused ¿pain and suffering, physical injury, loss of enjoyment of life, scarring, disfigurement, embarrassment, and economic and losses as a result of [their] strattice implant.¿ patient ¿suffered from wound infections and used a wound vac.¿ patient ¿wore an uncomfortable abdominal binder.¿ patient ¿had lifting restrictions and had to adjust [their] physical activities.¿ ¿it takes [the patient] longer to complete personal tasks.¿ patient ¿has difficulty taking long walks or walking up and down stairs.¿ patient ¿is dependent on others to help with the daily tasks he has difficulty completing himself.¿ the form lists the conditions that were treated were ¿ischemic colon with perforation, cholecystitis and infected marlex mesh with peritonitis, exploratory laparotomy, removal of infected mesh, subtotal colectomy with ileostomy, cholecystectomy, redo ventral hernia repair with strattice mesh¿ with approximate dates of treatment between (b)(6) 2014 and (b)(6).Patient was also treated for ¿bleeding from dermis around ostomy suction¿ on or about (b)(6) 2014.Patient received treatment for ¿open wound treated with a wound vac; ileostomy in place for ischemic colon¿ on or about (b)(6) 2014.Patient also underwent ¿open wound treated with wound vac and ileostomy in place for ischemic colon with perforation, granulation tissue excised, exploratory laparotomy, lysis of adhesions, ileostomy takedown, redo ventral hernia repair with strattice mesh, wound vac¿ with approximate dates of treatment between (b)(6) 2015 and (b)(6) 2015.Patient received treatment for ¿excessive drainage from incision site following ileostomy takedown¿ on or about (b)(6) 2015.Patient then underwent ¿wound vac removed, started on wet to dry dressing changes with dakins solution twice daily¿ on or about (b)(6) 2015.Patient had ¿wound check/maintenance; changed dressing¿ from 2014 to 2015.Patient received treatment for ¿chronic open abdominal wound, dehiscence with granulation tissue, sirs (systemic inflammatory response syndrome)¿ between (b)(6) 2016 and (b)(6) 2016.Patient had ¿ct abdomen & pelvis, large ventral hernia/diastases, open abdominal wall wound¿ on or about (b)(6) 2016.Patient received treatment for ¿abdominal wall pain - tender in right mid to lower abdomen, ct - possible adherence of bowel loops to the anterior abdominal wall¿ on or about (b)(6) 2016.The ppf form also indicates the patient was implanted with a non-abbvie device, ¿ventralight st¿ on (b)(6) 2014.The form indicates that this device was revised on (b)(6) 2014 due to ¿exploratory laparotomy, removal of infected mesh, subtotal colectomy with ileostomy, cholecystectomy, ventral hernia repair with strattice mesh.¿ as reported in the initial: limited information was reported through a legal event that a patient was implanted with strattice firm on (b)(6) 2014 and a 2nd strattice firm on (b)(6) 2015.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.This is the same event and the same patient reported under patient identifier cn-057782 (emdr-16127).This emdr is being submitted for the suspect product, first strattice firm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 25, FIRM
Type of Device
MESH, SURGICAL
Manufacturer (Section D)
BRANCHBURG
one millennium way
branchburg NJ 08876
Manufacturer (Section G)
BRANCHBURG
one millennium way
branchburg NJ 08876
Manufacturer Contact
christopher belle
1 millennium way
branchburg, NJ 08876
9089471470
MDR Report Key18461394
MDR Text Key332253266
Report Number1000306051-2024-00011
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K070560
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2015
Device Catalogue Number2025002
Device Lot NumberS11228
Was Device Available for Evaluation? No
Date Manufacturer Received04/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/12/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-